IL-1beta binding antibodies for use in treating cancer

Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ligueros-Saylan, Monica, Lau, Yi Yang, Libby, Peter, Matchaba, Patrice, Ridker, Paul, Ottewell, Penelope, Thuren, Tom, Dugan, Margaret
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.